Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...

A new study published in the New England Journal of Medicine showed that once-weekly injectable semaglutide led to ...

Fact checked by Nick Blackmer While taking GLP-1 medications like Ozempic may seem like a guaranteed way to reach your weight ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...

BOSTON -- Once-weekly semaglutide (Ozempic, Wegovy) improved taste sensitivity, changed gene expression in the tongue linked to taste perception, and changed brain activity in response to sweet ...

The 40-week SUSTAIN 7 trial investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin.

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...

According to Headline results from part 1 of the phase 3 ESSENCE trial, Semaglutide 2.4 mg may significantly improve liver ...

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight ...

Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, ...

SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy) significantly reduced hospital admissions ... “We hear regularly about different benefits of GLP-1 receptor agonists (GLP-1 RA).